These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 32120009)
1. Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy. Paulin FL; Hodgkinson KA; MacLaughlan S; Stuckless SN; Templeton C; Shah S; Bremner H; Roberts JD; Young TL; Parfrey PS; Connors SP Heart Rhythm; 2020 Jul; 17(7):1159-1166. PubMed ID: 32120009 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5. Dominguez F; Zorio E; Jimenez-Jaimez J; Salguero-Bodes R; Zwart R; Gonzalez-Lopez E; Molina P; Bermúdez-Jiménez F; Delgado JF; Braza-Boïls A; Bornstein B; Toquero J; Segovia J; Van Tintelen JP; Lara-Pezzi E; Garcia-Pavia P Heart Rhythm; 2020 Jun; 17(6):945-954. PubMed ID: 32062046 [TBL] [Abstract][Full Text] [Related]
4. The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus. Milting H; Klauke B; Christensen AH; Müsebeck J; Walhorn V; Grannemann S; Münnich T; Šarić T; Rasmussen TB; Jensen HK; Mogensen J; Baecker C; Romaker E; Laser KT; zu Knyphausen E; Kassner A; Gummert J; Judge DP; Connors S; Hodgkinson K; Young TL; van der Zwaag PA; van Tintelen JP; Anselmetti D Eur Heart J; 2015 Apr; 36(14):872-81. PubMed ID: 24598986 [TBL] [Abstract][Full Text] [Related]
5. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β. Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019 [TBL] [Abstract][Full Text] [Related]
6. TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations. Baskin B; Skinner JR; Sanatani S; Terespolsky D; Krahn AD; Ray PN; Scherer SW; Hamilton RM Hum Genet; 2013 Nov; 132(11):1245-52. PubMed ID: 23812740 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy. Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720 [TBL] [Abstract][Full Text] [Related]
8. TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy. Siragam V; Cui X; Masse S; Ackerley C; Aafaqi S; Strandberg L; Tropak M; Fridman MD; Nanthakumar K; Liu J; Sun Y; Su B; Wang C; Liu X; Yan Y; Mendlowitz A; Hamilton RM PLoS One; 2014; 9(10):e109128. PubMed ID: 25343256 [TBL] [Abstract][Full Text] [Related]
9. Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations. AbdelWahab A; Gardner M; Parkash R; Gray C; Sapp J J Cardiovasc Electrophysiol; 2018 Jan; 29(1):90-97. PubMed ID: 28960618 [TBL] [Abstract][Full Text] [Related]
10. Psychological Distress and Quality of Life in Participants Undergoing Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy Caused by TMEM43 p.S358L: Is It Time to Offer Population-Based Genetic Screening? Brothers C; Etchegary H; Curtis F; Simmonds C; Houston J; Young TL; Pullman D; Mariathas HH; Connors S; Hodgkinson K Public Health Genomics; 2021; 24(5-6):253-260. PubMed ID: 34500452 [TBL] [Abstract][Full Text] [Related]
11. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885 [TBL] [Abstract][Full Text] [Related]
12. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402 [TBL] [Abstract][Full Text] [Related]